Skip to content

Human Internal BIOASTER's Samples Collection

Non-interventional, Monocentric Study Aimed at Building up a Collection of Biological Samples Collected From Bioaster Collaborators for Scientific Purposes

Status
Not yet recruiting
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT06602388
Acronym
HIBISCUS
Enrollment
120
Registered
2024-09-19
Start date
2024-12-30
Completion date
2027-12-31
Last updated
2024-09-20

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Biological Samples

Keywords

Biological, samples, collection

Brief summary

BIOASTER is a Technological Research Institute dedicated to microbiology and infectious diseases. BIAOSTER s areas of expertise are organized around four research programs: 1/ Antimicrobials; 2/ Vaccines; 3/ Microbiota; 4/ Diagnostics. Hibiscus is a non-interventional, monocentric study aimed at building up a a collection of biological samples (stool, urine, saliva, buccal swab, nasal swab, superficial skin swab, hair) collected from BIOASTER employees. These samples to be used for scientific purposes including the technological development of Bioaster s collaborative and in-house research projects.

Interventions

OTHERBiological sampling

Collection of biological samples from healthy volunteers: Stool, urine, saliva, buccal swab, nasal swab, superficial skin swab, hair

Sponsors

Bioaster
Lead SponsorOTHER

Study design

Observational model
COHORT
Time perspective
PROSPECTIVE

Eligibility

Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
Yes

Inclusion criteria

Some inclusion criteria can be defined according to the needs of the scientific objective. For example, it is up to volunteers to decide whether or not to participate if they meet the following criteria: * Age criteria (e.g.: specific, non-identifying range sought: 30-40 years) * BMI criteria (for example: BMI between 18.5 and 29 kg/m2) * Gender criteria (e.g.: women only)

Exclusion criteria

Some of the following non-inclusion criteria may be defined according to the needs of the project: * Minor subject * Health criteria (e.g. presence or absence illness/infection/vaccination/allergy/anti-infective treatment in the last 3 months prior to the date of sampling) * Smoker status * Severe chronic illness (active cancer, HIV, severe renal failure, ongoing severe heart, liver or biliary disorders, arthritis) * Diagnosed acute or chronic gastrointestinal disease or complication (e.g. celiac disease, gastroesophageal reflux, gastric or duodenal ulcer, Crohn's disease, hemorrhoids, irritable bowel syndrome), In all cases, it will be requested that volunteers with the following criteria do not participate in the study: * Pregnant or breast-feeding women * Subjects under curatorship or guardianship * Subjects under legal protection.

Design outcomes

Primary

MeasureTime frameDescription
The number of analyzable samples collected for scientific purposes.3 years after the first inclusionThe number of analyzable samples collected for scientific purposes at the end of inclusion periode

Contacts

Primary ContactKarima BRAHAMI-AISSOU
karima.brahami-aissou@bioaster.org+336 34 53 37 84
Backup ContactMarie KOENIG
marie.koenig@bioaster.org+33 4 81 11 37 42

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026